Background: Two common mutations of the solute carrier family 4 member 1 (SLC4A1) gene, namely, Southeast Asian ovalocytosis (SAO) and band 3 Bangkok 1 (G701D), cause autosomal recessive distal renal tubular acidosis (AR dRTA) in ethnic Southeast Asian populations. In this study, we applied the high-resolution melting (HRM) method for screening of AR dRTA associated with SLC4A1 mutations in 10 new patients with unknown cause(s) of AR dRTA.
Common symptoms in patients with dRTA include growth retardation, osteomalacia, hyperchloremic metabolic acidosis, muscle weakness that is frequently accompanied by hypokalemia, metabolic bone disease, and nephrocalcinosis. [2] [3] [4] Autosomal dominant (AD) and autosomal recessive (AR) inheritance patterns have been described for this disease. Patients with AD dRTA have no disease symptoms until adolescence or adulthood, whereas patients with AR dRTA experience severe symptoms of disease that initially develop during childhood. 5, 6 Mutations of at least 3 genes, have been identified as the cause of dRTA. 3, 7, 8 However, approximately 20% of patients with primary dRTA have no mutations in these reported genes, and other novel disease-causing genes have not yet been identified. 6 The solute carrier family 4 member 1 (SLC4A1) gene (OMIM+ 109270), which is approximately 20 kilobase (kb) in size, is located on chromosome 17 (17q21.31). The human SLC4A1 gene encodes erythroid anion exchanger Therefore, SLC4A1 mutations can cause 2 distinct disorders, namely, morphologic changes in red blood cells and dRTA, attributable to defective expression of eAE1 and kAE1 in erythrocytes and α-intercalated cells, respectively. 10 SLC4A1 mutations have been reported to cause AD and AR dRTA. The mutations that cause AD dRTA are R589H, R589S, R589C, S613F, and R901X, 3, 4, [11] [12] [13] whereas the mutations that cause AR dRTA are band 3 Bangkok 1 (G701D)/G701D, Southeast Asian ovalocytosis (SAO)/ G701D, SAO/V850, SAO/A858D, V850/V850, V850/A858D, V488M/V488M, G701D/S773P, and SAO/Q759H. [14] [15] [16] [17] [18] [19] In Thailand, the homozygous SLC4A1 G701D mutation and the compound heterozygous SAO/G701D, SAO/ R602H, G701D/S773P, and G701D/A858D were reported to cause AR dRTA. 14, 17, 18, 20 A previously conducted population survey 21 found that SAO mutation caused by a deletion of 27 base pairs (bp) in exon 11 (NM_000342.3: c.1199_1225del27, p.Ala400_Ala408del), which results in an in-frame lack of 9 amino acids in the protein, is the common mutation in Southern Thailand, with an estimated allele frequency of 1.70%. Also, band 3 Bangkok 1 (G701D) (NM_000342.3: c.2102G>A, p.Gly701Asp), which is caused by a base substitution in exon 17 leading to a missense (glycine to aspartic acid) mutation at codon 701 of the protein, 22 is the most prevalent mutation in northeastern Thailand, with an estimated allele frequency of 0.73%. 21 These data indicate that SAO and G701D mutations are 2 common SLC4A1 mutations that cause AR dRTA in the Thai population. However, the prevalence of SLC4A1 mutations in other Asian populations is mostly unknown.
A previous work coauthored by 3 of us 23 reported on the development of the high-resolution melting (HRM) method and its optimization for analysis of SLC4A1 mutations and polymorphisms. HRM was reported to be a more rapid method than other germane methods. 24, 25 However, HRM analysis is not yet routinely used for diagnosis of SLC4A1 mutations in DNA specimens from patients with dRTA.
In the present study, we tested the HRM method in new cases of dRTA with no known molecular defects. Then, we confirmed the reliability of HRM by using polymerase chain reactionrestriction fragment-length polymorphism (PCR-RFLP) and DNA sequencing techniques to conduct molecular diagnosis of AR dRTA associated with SLC4A1 mutations.
Materials and Methods

Patients
The 
Genomic DNA Extraction and Polymerase Chain Reaction (PCR) Amplification
Genomic DNA specimens of patients with AR dRTA and their family members were extracted from peripheral blood specimens using the Puregene Blood Core Kit B (QIAGEN). The concentration of genomic DNA specimens was diluted to 25 ng per µL after measurement using the spectrophotometric method. The primers used for detection of SAO and G701D mutations ( Table 2) were designed from the SLC4A1 gene sequence (GenBank accession number GI:171460929) using Primer3 software program (Whitehead Institute for Biomedical Research), as previously described. 27, 28 PCR reactions were performed in a volume of 20 µL that contained 100 ng genomic DNA mixed with 0.5 µM of each primer pair, 0.25 mM deoxyribonucleotide triphosphate (dNTP), 1X reaction buffer, and 0.5 units of DNA polymerase (GeNet Bio) in a PCR tube. Sterile distilled water was added to achieve the total volume. PCR was conducted in a Biometra Tprofessional Basic ThermalCycler (Analytik Jena AG). The PCR condition was set as follows: initial denaturation at 94°C for 10 minutes, followed by 40 cycles of 94°C for 25 seconds, annealing at 67°C for 25 seconds, extension at 72°C for 25 seconds, and final extension at 72°C for 5 minutes. The PCR products were used for analysis of SAO and G701D mutations using the HRM and PCR-RFLP methods.
Screening of SAO and G701D Mutations Using the HRM Method
HRM analysis for screening of SAO and G701D mutations was modified from the method that was previously developed and reported by 3 of us. 23 After PCR amplification, HRM reactions were performed in 10-µL volumes containing 8 µL of PCR product, 1X ResoLight Dye (F. Hoffmann-La Roche, Ltd), and sterile distilled water to achieve the total volume in a 96-well plate.
HRM analysis was performed in a LightCycler 480 II realtime PCR cycler (F. Hoffmann-La Roche, Ltd). Before the HRM step, the PCR products were heated to 97°C for 30 seconds and then cooled to 40°C for 30 seconds.
Melting curves were acquired by increasing the temperature to 97°C with 25 acquisitions of continuous florescence detection. LightCycler 480 Gene Scanning Software (F. Hoffmann-La Roche, Ltd.) was used to create the melting curves and difference plots. For HRM analysis of G701D mutation, the tested specimens were further analyzed by spiking with PCR product containing homozygous wildtype, to allow for the detection of the heteroduplex DNA molecule and to distinguish between homozygous wild-type and homozygous variant that could not be differentiated in the first scan.
Analysis of G701D Mutation by PCR-RFLP
To confirm the result of HRM analysis, the genotype of SLC4A1 G701D in all patients and their family members was performed using the conventional PCR-RFLP method. The 173-bp PCR product of exon 17 was digested with 10 U of HpaII (New England BioLabs) overnight at 37°C. Digested PCR fragments were analyzed by 2% agarose gel electrophoresis, and the results were recorded and analyzed.
DNA Sequencing Analysis
To confirm the result of mutation screening using HRM, we performed DNA sequencing. A pair of SAO primers ( Table 2 ) and a pair of primers (SLC4A1-EX17L: 5′-TGGAGGAGGCAGGGGAGAAC-3′ and SLC4A1-EX17R: 5′-GGGGCAGGAGGATGGTGAAG-3′) were used to amplify exons 11 and 17, respectively, of SLC4A1. The PCR products were purified using the GenepHlow T Gel/PCR Kit (Geneaid Biotech Ltd). Purified PCR products were analyzed by DNA 
Results
Subjects and Clinical Study
We included 10 patients with dRTA (6 girls and 4 boys, aged 11 months to 13.8 years) from 8 genetically unrelated families (K1-K8) in this study. We also included and analyzed data from 21 family members of the 10 included patients with dRTA (from 8 genetically unrelated families). Demographic and clinical characteristics of the 10 pediatric patients with dRTA are shown in Table 1 . Most patients presented with failure to thrive and muscle weakness. Four patients (1 each from families K1, K2, K3, and K8) had genu valgum, and 2 of them also had rachitic rosary. Nephrocalcinosis was present in 2 patients (1 each from families K3 and K7 
Screening of SAO and G701D Mutations Using the HRM Method
We extracted genomic DNA from peripheral blood specimens collected from 10 children with AR dRTA and 21 family members from 8 families. Exons 11 and 17 of SLC4A1 were amplified from genomic DNA specimens using PCR. PCR products were subjected to HRM analysis to detect the most common SLC4A1 mutations (SAO and G701D). We analyzed the melting profiles and difference plots of SAO and G701D mutations.
HRM results showed that all patients had no SAO mutation ( Figure 1A ) but they all had homozygous G701D mutation ( Figure 1B) . The first scan for G701D mutation revealed that all patients had homozygous wild-type or homozygous G701D genotype because the difference plots of both genotypes were not different, whereas the difference plots of heterozygous G701D were different than those of the other genotypes. Difference plot results from the second scan (spiked with GG) indicated that all patients had homozygous G701D genotype. Scan results from family members of patients with dRTA showed homozygous wild-type or heterozygous G701D genotypes (data not shown).
Analysis of G701D Mutation by PCR-RFLP and DNA Sequencing
We performed PCR-RFLP to confirm the result of SLC4A1 G701D mutation screening using HRM analysis. The 173-bp PCR product of exon 17 was digested with restriction enzyme HpaII to generate 3 patterns that represented the following 3 different genotypes: homozygous wild-type (GG; 106 and 67 bp), heterozygous G701D (GA; 173, 106, and 67 bp), and homozygous G701D (AA; 173 bp) ( Figure 2) . The results showed that all 10 patients with AR dRTA from 8 families had only the undigested fragment of exon 17 with size 173 bp, which indicated that all patients carried the homozygous G701D mutation.
Regarding the analysis of family members of patients with AR dRTA, most had the heterozygous G701D genotype; however, 4 members of family K7 (grandmother, aunt, uncle, and cousin of patient) had the homozygous wild-type genotype ( Figure 2) . The results of SLC4A1 G701D mutation genotyping using PCR-RFLP corresponded to the results of HRM analysis (Table 3) .
Also, we performed DNA sequencing for SAO and G701D to confirm the results of HRM analysis. The result showed that a deletion of 27 bp in exon 11 of SLC4A1 was not found in all patients, indicating that all patients had no SAO mutation ( Figure 3A) . However, DNA sequencing revealed 
Figure 1
Melting curves and difference plots of solute carrier family 4 member 1 (OMIM+ 109270) Southeast Asian ovalocytosis (SAO) and band 3 Bangkok 1 (G701D) mutation analyses in 10 patients with autosomal recessive distal renal tubular acidosis (dRTA), determined via the high-resolution melting (HRM) method. A, SLC4A1 SAO mutation. Difference plots of amplicons from homozygous wild-type (normal) and heterozygous SAO mutation could be differentiated. No patients had SAO mutation, when compared with DNA specimen material carrying known SAO mutation. B, SLC4A1 G701D mutation. Difference plots of amplicons from homozygous wild-type (GG) and homozygous G701D (AA) were clustered together in the first scan. These 2 genotypes were differentiated after spiking with a DNA specimen of homozygous wild-type (GG). All patients had homozygous G701D mutation, when compared with DNA specimens carrying known heterozygous G701D mutation and wild-type.
a nucleotide substitution (GGC change to GAC) at codon 701, which indicated homozygous G701D mutation in all 10 patients with AR dRTA ( Figure 3B ). In contrast, patient family members had homozygous wild-type or heterozygous G701D genotypes.
Discussion
Only the mutations in 1 of 3 known genes, namely, the SLC4A1 gene, have been reported to cause AD and AR dRTA in an ethnic Thai population. 13, 14, 17, 18, 20, 22 Of these, SAO and G701D are the 2 most common SLC4A1 mutations that cause AR dRTA in ethnic Thai patients. 21, 30 In this study, all specimens were initially investigated for these common mutations using HRM analysis. The results revealed that homozygous G701D mutation caused AR dRTA in all 10 patients with AR dRTA in this study.
In several previous reports, conventional methods, such as polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP), PCR-RFLP, and DNA sequencing techniques were performed to analyze SLC4A1 mutations in patients with dRTA. 17, 18, 21 Although reliable and valuable, those methods are complicated, time consuming, and labor intensive. With those drawbacks in mind, the HRM method was developed and optimized for detection of SLC4A1 mutations and polymorphisms. 23 The HRM method is an attractive technique for analysis of genetic variations due to its ability to identify
Figure 2
Analysis of solute carrier family 4 member 1 (SLC4A1) band 3 Bangkok 1 (G701D) mutation in 10 patients with autosomal recessive distal renal tubular acidosis (dRTA) and their family members from 8 families (K1-K8), using polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP). HpaII-digested DNA patterns were separated by electrophoresis on 2% agarose gel. The amplified polymerase chain reaction (PCR) fragment with the wild-type could be cleaved with HpaII. In contrast, the amplified PCR fragment with the G701D mutation could not be cleaved with this enzyme. All 10 patients had homozygous G701D (AA; 173 bp). The family members of patients had heterozygous G701D (GA; 173, 106, and 67 bp) or homozygous wild-type (GG; 106 and 67 bp). Tested DNA specimens from patients and their family members were loaded in order, according to the pedigree above the gel. The last 3 lanes show known specimens with homozygous wild-type, heterozygous G701D, and homozygous G701D. M indicates standard DNA markers.
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heterozygous single-base changes in PCR products with high sensitivity and specificity. Also, the HRM method is rapid, convenient, powerful, and reproducible. 24, 25 However, in the previous report coauthored by 3 of us, 23 the HRM method was not used for routine screening of the SLC4A1 mutations in DNA specimens from patients with dRTA. In the present study, we applied HRM for detection of the 2 most common SLC4A1 mutations in children with AR dRTA from northeastern Thailand.
All patients with AR dRTA in this study had had symptomatic disease since childhood, and most of them presented with failure to thrive and muscle weakness. Exons 11 and 17 of SLC4A1 were amplified from genomic DNA from the study group for analysis of common SLC4A1 mutations (SAO and G701D), using HRM and PCR-RFLP. The result of HRM analysis indicated that all patients had homozygous G701D genotype, whereas the parents of patients had heterozygous G701D and other family members had heterozygous G701D or homozygous wild-type.
We consider it important that all results yielded by HRM analysis were corroborated by PCR-RFLP and direct DNA sequencing. The results also indicate that the HRM method had 100% effectiveness in screening for SLC4A1 mutations in DNA specimens with unknown cause. However, a limitation of HRM is that different sequence variations present in the same amplicon may result in a similar HRM profile. Thus, PCR-RFLP or direct DNA sequencing is recommended as a confirmatory method in case of suspicion. Our finding in this study that homozygous SLC4A1 G701D mutation caused AR dRTA in all 10 patients from the northeast region of Thailand is consistent with the findings of the previous report coauthored by 2 of us 17, 21 that G701D mutation might arise in northeastern Thailand and that a higher allele frequency of the SLC4A1 G701D mutation was found in northeastern Thailand. Also, the finding of no SAO mutation in all studied subjects corresponds the finding from the previous report, coauthored by 2 of us, 21 that SAO mutation is the common mutation with high allele frequency in Southern Thailand. Also, this result supports the currently accepted belief that homozygous SLC4A1 G701D mutation is the most common cause of AR dRTA in northeastern Thailand.
Figure 3
Genotyping of solute carrier family 4 member 1 (SLC4A1) Southeast Asian ovalocytosis (SAO) and band 3 Bangkok 1 (G701D) mutations by DNA sequencing. A, SLC4A1 SAO mutation. A 27-nucleotide deletion in codons 400 to 408 of exon 11, corresponding to heterozygous SLC4A1 SAO mutation, was not found in any patients, when compared with DNA specimen material carrying known SAO mutation (control specimen). B, SLC4A1 G701D mutation. An amplified DNA fragment of exon 17 from individuals with normal, heterozygous, and homozygous G701D showed nucleotide sequences of codon 701 of GGC/GGC, GGC/GAC, and GAC/GAC, respectively. This finding indicates G701D mutation in all 10 patients in the cohort.
DOI: 10.1093/labmed/lmy051
Conclusions HRM analysis is a simple and rapid screening method for common SLC4A1 mutations that can be used as molecular diagnostic tool for AR dRTA associated with SLC4A1 mutations in Thai pediatric patients and other Southeast Asian pediatric patients. Also, HRM can be used to screen carriers with SLC4A1 mutations and in a genetic counseling setting for prenatal diagnosis in affected families. LM
